17ME13 - Immune Checkpoint Inhibitors in Cancer Therapeutics, Part 2
$15.00$0.00
Speaker: Donald Yance. Continued from Part 1 the methods of combining checkpoint inhibitors (mainly a class of drugs called Programmed cell death 1 [PDL-1] inhibitors), with botanical and nutritional programs for advanced cancer patients are discussed.